← Evidence map

ArticleScientific reports2021

MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer.

En-Chi Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34172788